Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christophe Rey
Observed name:
Christophe REY
ORCID:
0000-0001-9606-8525
Observed ORCID:
0000-0001-9606-8525
OpenAlex ID:
A5080080314
Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures
2025
·
Florent Peyraud
, Jean-Philippe Guégan
, et al.
·
Cell Reports Medicine
·
76
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer
2023
·
Alban Bessede
, Florent Peyraud
, et al.
·
Clinical Cancer Research
·
74
PDF
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
2024
·
Jean-Philippe Guégan
, Florent Peyraud
, et al.
·
Cell Reports Medicine
·
53
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non–Small Cell Lung Cancer
2023
·
Alban Bessede
, Florent Peyraud
, et al.
·
Clinical Cancer Research
·
34
PDF
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas
2024
·
Jean Philippe Guegan
, Nathan El Ghazzi
, et al.
·
Journal of Hematology & Oncology
·
15
PDF
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
·
Clinical Cancer Research
·
4
PDF
Abstract 7471: Cancer-associated fibroblasts drive T cell infiltration and resistance to immunotherapy in non-small cell lung cancer with mature tertiary lymphoid structures
2024
·
Florent Peyraud
, Jean-Philippe Guegan
, et al.
·
Cancer Research
·
4
Abstract 6767: Cancer-associated fibroblasts promote T-cell exclusion and resistance to immunotherapy in non-small cell lung cancer with tertiary lymphoid structures
2023
·
Florent Peyraud
, Jean-Philippe Guegan
, et al.
·
Cancer Research
·
3
Identification of super-exhausted T cells: A novel population predictive of response to immunotherapy.
2022
·
Florent Peyraud
, Jean-Philippe Guegan
, et al.
·
Journal of Clinical Oncology
·
3
Data from TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer
2024
·
Alban Bessede
, Florent Peyraud
, et al.
·
1
Abstract 2578: High regulatory T cells infiltrate within tertiary lymphoid structure restricts response to immune checkpoint blockers in sarcomas
2022
·
Florent Peyraud
, Jean-Philippe Guegan
, et al.
·
Cancer Research
·
1
Impact of acetaminophen on the efficacy of immunotherapy in patients with cancer.
2022
·
Alban Bessede
, Aurelien Marabelle
, et al.
·
Journal of Clinical Oncology
·
1
Supplementary Table S5, S6 from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Figure S1 from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Supplementary Table S4 from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Data from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Supplementary Table S7 from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Figure S2 from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Supplementary Table S1, S2, S3 from Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic Sarcoma
2026
·
Mariella Spalato Ceruso
, Jean-Philippe Guégan
, et al.
Abstract 6472: Tumor-cell NY-ESO-1 expression predicts poor response to PD-1/PD-L1 blockade in NSCLC
2026
·
Adele Lerue
, Jean-Philippe Guegan
, et al.
·
Cancer Research
Abstract 4972: KIT exon 9 versus exon 11 mutations imprint distinct spatial and phenotypic immune microenvironments in gastrointestinal stromal tumors
2026
·
Jean-Philippe Guegan
, Jean-Michel Coindre
, et al.
·
Cancer Research
Abstract 2419: Impact of immune contexture on immunotherapy response in NSCLC: insights from multiplex IHC and machine learning-based phenotyping
2025
·
Jean-Philippe Guegan
, Imane Nafia
, et al.
·
Cancer Research
Supplementary Table S3 from TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer
2024
·
Alban Bessede
, Florent Peyraud
, et al.
Supplementary Table S2 from TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer
2024
·
Alban Bessede
, Florent Peyraud
, et al.
Supplementary Figure S1 from TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer
2024
·
Alban Bessede
, Florent Peyraud
, et al.
Show more works
View as search
Works count:
52
Citation count:
269
H-index:
5
I10-index:
5
Year
Topic
Type